Clinical Trial Update: A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating SC0062 capsule for IgA nephropathy with proteinuria is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• SC0062 Capsule

Snippet

Sponsor: Biocity Biopharmaceutics Co., Ltd. | Conditions: IgA Nephropathy (IgAN) | Phase 3 | Status: RECRUITING